Main Menu

Transform Healthcare Evidence - at Agent Speed.

100+ years of HEOR expertise × governed Agentic AI = regulator‑ready insights in ≤ 30 days.

Book a 15‑min discovery call
Download The Playbook

Ready to see agentic speed?

Why We Exist (Problem/Tension)

Evidence requirements are soaring, yet traditional HEOR/Access workflows can’t keep pace.

HEOR and market-access teams still lose up to 60 % of their week to manual, low-value chores while most AI pilots stall in compliance limbo.

Our agentic ecosystem removes both bottlenecks, delivering transparent, audit-ready automation instead of black-box risk.

Who Are We?

Deep Domain + AI Engineering

HEOR Scientists

With cumulative 100+ years of experience in HEOR, real-world evidence, and market access, our HEOR scientists shape every AI agent’s logic and outputs. Their deep domain expertise ensures that AI delivers not just speed but scientifically valid, regulator-ready insights you can trust.

AI Engineers

Our AI engineers specialize in building healthcare-safe AI systems. From prompt libraries to bias detection and audit trails, they embed responsibility into every layer. Their role ensures that every model scales securely, explains itself clearly, and supports; not replaces expert decision-making. Knitting AI with HEOR is an art we are mastering in the new world.

Rectangle 9685

Cross-functional Pods

We embed domain and tech talent in agile pods: HEOR scientists, AI engineers, and solution designers working side-by-side. This integrated model means we build faster, align better, and ensure that every agent reflects both the complexity of healthcare and the guardrails of responsible AI.

Responsible AI

Governed from Day 1

True governance refrains from using jargon such as ‘Black Box’, ‘Cannot be explained’ & believes in taking onus to monitor performance, identify gaps & rectify the machine. That is the reason that strategizing & articulating human intervention at right places in the right time while working with AI is a serious discipline.

Transparent & Auditable

AI is not just about mimicking humans, rather reasoning like humans. Humans are complex and a human like complexity requires transparency and systematic validation and audit mechanism to ensure preferred behaviour.

Regulation-ready

In Healthcare a regulation-ready AI is inevitable. AI systems must meet stringent standards for safety, transparency, and efficacy, complying with evolving regulatory frameworks. All ConnectHEOR applications are curated with utmost priority to secure and compliant architecture

AI Ecosystem

(Hover over donut bars)

(Touch and long press donut bars)

connectheor

100 + pre‑built PoCs ready to deploy

How We Deliver

30‑Day Proof‑of‑Concept

Tell us a challenge that is not yet solved, and we shall produce a working proof of how you can tackle the challenge using our latest AI developments

Therapeutic Suite Roll‑out (3‑6 mo)

Get on a journey with us to curate something revolutionary with scalable and agile tech infrastructure which you can roll-out to your customers or implement company-wide to 10x your performance

Centre‑of‑Excellence Partnership (multi‑year)

Join hands to become the market pioneers in top-class AI driven research in healthcare. Dive early into futuristic research ideas around big-data, Reasoning Models, Quantum-AI etc.

Learn with Us (Flagship Course)

Generative & Agentic AI for HEOR Professionals

Cohort #1 Q1 2026 (20 seats).

Hands-on, no-fluff course built by HEOR experts and data scientists from consulting and industry—specifically for health economics professionals who want to stay ahead in a rapidly evolving landscape.

Learn how to use Gen‑AI and agentic tools to automate evidence synthesis, generate smarter reports, and build mini-AI assistants tailored to your daily HEOR workflows. Walk away with ready-to-use templates, prompt libraries, and live workflows that you can plug into your projects. Limited to just 20 seats – join the waitlist now and future-proof your HEOR skillset.

Join the Wait List

AI Resources Hub

View All

Advancing unanchored simulated treatment comparisons: a novel implementation and simulation study

Shijie Ren, Sa Ren, Nicky J. Welton, Mark Strong
Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden
Srivastava T, Prabhu V, Li H, Xu R, Zarabi N, Zhong Y, Pellissier J, Perini R, Ronald de Wit, Mamtani R
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review
Tobias Sydendal Grand, Shijie Ren, James Hall, Daniel Oudin Åström, Stephane Regnier, Praveen Thokala
Understanding Breast Cancer Patient Pathways and their impact on Survival in Mexico
Fatin Izzati Ramli, Praveen Thokala, Thaison Tong, Karla Unger-Saldaña
Characteristics and lipid lowering treatment patterns in patients with lipoprotein(a) test: a real-world US study
Hu X, Cristino J, Gautam R, Mehta R, Amari D, Heo J, Wang S, Wong N

Responsible AI

Industry Proof (AI Research & Talks)

ISPOR Atlanta 2024

1 Podium Presentation
4 Posters

MAY 05 2024

HTAi 2024

1 Presentation

JUN
15
2024

ISPOR EU 2024

7 Posters

NOV
18
2024

ISPOR Montreal 2025

5 working Agents

MAY 13 2025

ISPOR Glasgow 2025

8 working Agents
5 posters

NOV 9 2025

Newsletter

Keep up with our latest news and events. Subscribe to our newsletter

Judit Banhazi

Specialty
Value and Access

Role
Vice President

Degree
MD Medicine, JD Law

Judit Banhazi

MD Medicine, JD Law

Judit Banhazi, based in Basel, Switzerland, brings over 20 years of experience in HEOR, Market Access, and Health Policy.
She has led HEOR strategies in hematology and initiated EU HTA policy activities. Judit began her career as a physician and has worked at prime global pharma companies. Her academic prowess is excellent with a peculiar combination of an MD in Medicine and a JD in Law, she has been at forefront of health economics by being involved in HTA policy discussions with EFPIA and HTAi.
Known for her collaborative spirit and practical approach, Judit is passionate about learning and delivering quality work. Outside of work, she enjoys spending time with family and friends, travelling, and running.

Adam Ball

Specialty
Business Development Manager

 

Adam Ball

Business Manager

I am delighted to be part of the team here at ConnectHEOR. To tell you a bit about me, I have 10 years experience within Talent Acquisition within HEOR, RWE and Market Access. I have built a global network during this time and am excited to utilize this to help us grow as business. 

 

Outside of work I love sports, playing football and squash regularly, as well as going to the gym. I also enjoy watching sports mainly football and tennis. I have a new born daughter too so she is taking up a lot of my time and is a bundle of joy. I also play drums and like to think I have a broad taste in Music.

 

Eleni Tente

Specialty
Medical writing, Evidence planning

Role
Consultant, Medical writer

Degree
PhD – Molecular biology and genetics

Eleni Tente

PhD – Molecular biology and genetics

Eleni Tente is an experienced medical writer with proven ability to translate complex scientific information into clear, concise, and impactful content to diverse audiences. She has a strong background in integrated evidence planning, publications, internal communications and e-learning development, complemented by an understanding of various therapeutic areas.

Eleni holds a PhD in molecular biology and genetics from the University of Cambridge and an MSc in plant genetic manipulation from the University of Nottingham.

In her free time, Eleni enjoys diving into a good book, fishing along the coast, or planning her next thrilling scuba diving adventure to swim with sharks.

Syed Salleh

Specialty
HTA Modelling and Discrete-event Simulation

Role
Consultant, Modeling & Analytics

Degree
PhD – Health & Related Research

Syed Salleh

PhD. Health & Related Research

Syed Salleh brings extensive experience in HTA modeling, having successfully led the development of both de novo and adaptation models for HTA listings across multiple countries, including Malaysia, Philippines, and the UK. His work spans key therapeutic franchises such as oncology, cardiometabolic, and respiratory. Syed has also delivered critical insights to healthcare professionals through MYSPOR, ITTP, and IKN virtual CME events and numerous publications.

He holds a PhD in Health and Related Research from the School of Health and Related Research (ScHARR) at the University of Sheffield, UK, with a specialization in HTA and operational research, specifically in discrete-event simulation (DES) technique.

During his time in a leading pharmaceutical company, Syed played a key role in securing the listing of several key products in the Malaysia Ministry of Health Formulary and served as the primary contact for DES-related projects.

Besides work, Syed enjoys traveling, listening to music, and spending quality time with his family.

Thai-Son Tong

Specialty
Model Conceptualization and Data Analytics

Role
Senior Consultant

Degree
PhD – Health Economics

Thai-Son Tong

PhD. Health Economics

Thaison Tong has extensive work experience in health economics, decision modelling and big data analysis. He has a unique mix of experience in HEOR and RWE related research in academia and pharmaceutical industry. His expertise lies in health technology assessments (HTA), health economic modelling, simulation modelling, big data analytics and decision analysis. He has hands-on experience in a range of software and programming languages including R, R Shiny, R Markdown, Python, MS Excel, VBA, and Simul8. He has substantial experience of the health care system in the UK and other European countries.

Thaison has direct experience in building cost-effectiveness models from scratch and conducting big data analysis in several disease areas including dementia, vascular disease, and cancer.

Thaison’s PhD focus was to develop a de novo patient level model for the evaluation of different cognitive screening tests for early detection of dementia and mild cognitive impairment in primary care. He also looked at different methods for conducting economic evaluation in health care taking a broader/societal perspective. In addition, he investigated the use of Multiple Criteria Decision Analysis (MCDA) for economic evaluation.

Thaison also holds Academic Researcher position in School of Health and Related Research (ScHARR), University of Sheffield, UK and Honorary Researcher position in University of Bristol, UK.

Thaison’s likes to meditate, and play badminton, basketball and tennis.

Shilpi Swami

Specialty
Consulting and strategy

Role
Vice President

Degree
MSc. International Economics

Shilpi Swami

MSc. International Economics

Shilpi Swami is an internationally recognized leader in consulting, named among the World’s Top 25 Women Leaders in Consulting 2025 – a distinction that spans the entire consulting industry. She also serves as Chair-Elect of the ISPOR Oncology Special Interest Group and is a frequent speaker at leading scientific and policy forums, where she brings clarity and authority to complex healthcare access challenges.

As Vice President of Consulting and Strategy at ConnectHEOR, Shilpi provides both scientific and strategic leadership, guiding evidence generation and market access initiatives across Europe, North America, Latin America, Asia, and Australia. She has led numerous high-stakes HTA submissions and access strategies, combining methodological rigor with practical solutions that resonate with regulators, payers, and biopharma stakeholders.

Her multidimensional career – spanning academia, consulting, and biopharma equips her with a rare ability to bridge perspectives across research, policy, and industry. Previously a Research Fellow at the University of York, she contributed to advancing best practices in public health and health economics.

Shilpi is widely respected not only for her expertise but also for her people-first approach. She embodies the belief that Kindness is Cost-Effective™, demonstrating that strength in leadership comes from pairing scientific excellence with empathy, collaboration, and impact.

Hugo Pedder

Specialty Statistical Analysis and Evidence Synthesis

Role Senior Consultant

Degree PhD – Statistical Modelling

Hugo Pedder

PhD – Statistical Modelling

Hugo brings in a wealth of experience to ConnectHEOR from his extensive work in academia, focusing primarily on evidence synthesis and meta-analysis. Hugo holds PhD in Statistical Modelling from University of Briston and MSc in Medical Statistics from the London School of Hygiene and Tropical Medicine, and his background in neuroscience remains a passionate interest. Alongside working with ConnectHEOR, Hugo continues to part of NICE committee. His expertise includes advanced indirect treatment comparisons technique and has extensive experience of working with the NICE in UK. 

Beyond professional endeavors, Hugo is an enthusiastic outdoor adventurer, particularly enjoying mountain activities, climbing and ski mountaineering. From building rafts to exploring rivers in north of Sweden, he has lived an adventurous life outside of work and plans to continue to do so.

Kunal Hriday

Specialty
AI Strategy

Role
Director

Degree
MSc. Quantitative Economics

Kunal Hriday

MSc. Quantitative Economics

Kunal Hriday is a business strategy and data science professional with experience in helping organizations crack through notorious business challenges. Kunal is proficient building scalable AI products, specialized Intelligence, automations, business analytics, product lifecycle management and business development. Working as a Data science professional he has spent time in problem solving across variety of industries including Banking, logistics and Health and is now fully dedicated to HEOR. Kunal has hands on experience in various statistical programming tools and languages.

He also holds a masters’ in Quantitative Economics from Indian Statistical Institute and a bachelors’ degree in Business Economics. Excellent in business communication, he is passionate about studying environmental economics and related theories of welfare optimization.

Kunal is trained in Indian Classical Music and finds solace in music when not at work.

Raju Gautam

Specialty
Evidence Review

Role
Principal Consultant

Degree
PhD (Pharmacy)

Raju Gautam

PhD Pharmacy

Raju Gautam spearheads evidence review at ConnectHEOR and  has extensive work experience in evidence review and synthesis, value communications, scientific publications, medical writing and project management.
His expertise lies in systematic and targeted literature reviews, meta-analyses, network meta-analyses, value communications (AMCP and Global Value Dossiers), RWE study design and publications (manuscripts, posters, and abstracts).
He has experience working in Global pharma companies, consulting and CRO environment for several therapy areas including Cardiovascular, Oncology, Neurology, Respiratory, Ophthalmic, Rare Diseases, and Vaccines. He has more than 40 publications in international journals as an author.
Raju also likes jogging, yoga and meditation.

Radha Sharma

Specialty:
Patient preference research, survey, In-depth interviews, COA, Evidence review and conceptualisation of study

Role:
Director – Patient-Centered Outcomes Research

Degree:
MBBS (Bachelor of Medicine and Bachelor of Surgery), PhD (Global Public Health) – University of York

Radha Sharma

PhD (Global Public Health)

Radha Sharma spearheads Patient-Centered Outcomes Research at ConnectHEOR. She has a background in medicine, public health, and epidemiology.

Her expertise includes global health research, preference elicitation, mixed-method studies, consensus workshops, qualitative health research, epidemiological analysis of big data sets, RWE study design, scientific writing, and literature reviews. Her primary focus is integrating patient perspectives into all stages of health technology assessment (HTA) and healthcare decision-making processes.

Her extensive expertise in mixed-method studies and active patient/stakeholder engagement ensures that her research is methodologically rigorous and patient-centric. Radha is an avid hiker and enjoys exploring the beautiful Canadian Rockies.

Kate Ren

Specialty
Statistical Analysis and Evidence Synthesis

Role
Director of Statistics

Degree
Ph.D Probability and Statistics

Kate Ren

PhD Probability and Statistics

Kate spearheads Statistics and Evidence Synthesis at ConnectHEOR. She has more than 10 years of experience in conducting statistical analysis in HTA. Kate has PhD in Probability and Statistics specialising in Bayesian methods in clinical trial design.

She specializes in Bayesian methods in health economics and the elicitation of experts’ beliefs and has extensive experience of conducting evidence synthesis, including, meta-analysis, network meta-analysis, MAIC, STC, ML-NMR etc. Besides working with ConnectHEOR, she is also a part of NICE Committee and University of Sheffield.

Tushar Srivastava

Specialty
Decision Modelling and AI Initiatives

Role
Director

Degree
MSc – Statistics and Computing

Tushar Srivastava

MSc – Statistics and Computing

Tushar Srivastava is a health economics and outcomes research (HEOR) leader whose journey spans academia, consulting, and the life sciences industry – bringing a rare breadth of perspective to evidence generation. Endorsed as a Global Talent by the Royal Society, UK, and holding an MSc in Statistics and Computing, he has authored numerous publications in modeling, indirect treatment comparisons, patient-centered outcomes research, evidence reviews, and AI.

He has built a reputation for uniting scientific excellence with technological innovation. From developing decision models himself to shaping and mentoring world-class modeling teams, Tushar has consistently advanced the science and practice of HEOR with a forward-looking, technology-driven vision.

At ConnectHEOR, Tushar directs HEOR activities and leads the integration of responsible AI into evidence generation. His vision is transforming the field from a human-only framework to an intelligent, interactive, and scalable hybrid intelligence framework – where human expertise works in synergy with AI.

Working diligently to improve patient lives through research and technology, he brings scientific rigor and technological foresight to projects across diverse therapy areas and health technologies, including pharmaceuticals, medical devices, diagnostics, digital health, and public health programs. His work is widely published and presented internationally, reflecting both methodological depth and innovative thinking.

He believes that Kindness is Cost-Effective™ and continues to ensure that ConnectHEOR’s science and technology are always guided by a human-centered ethos.